Drug interactions of clinical importance with methadone and buprenorphine

American Journal on Addictions

Volumn 19, Issue 1, 2010, Pages 2-3

  McCance Katz, Elinore F ^a,c   Mandell, Todd W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Vermont Office of Drug and Alcohol Programs   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; DIAMORPHINE; METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVERSE OUTCOME; ANTIBIOTIC RESISTANCE; DISEASE TRANSMISSION; DRUG DEPENDENCE; DRUG INTERACTION; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL ERROR; MORBIDITY; MORTALITY; PRESCRIPTION; PUBLIC HEALTH PROBLEM; SELF MEDICATION; UNITED STATES;

ANALGESICS, OPIOID; BUPRENORPHINE; DRUG INTERACTIONS; HUMANS; METHADONE; NARCOTICS;

EID: 77149160385     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2009.00011.x     Document Type: Editorial

References (2)

1. Committee on Quality of Health Care in America: Institute of Medicine. To Err Is Human: Building A Safer Health System. Washington, DC : National Academy Press 2000.
2. Lazarou J, Pomeranz B, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA. 1998 279 : 1200 1205.